These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 23118928)
1. In vivo and in vitro suppression of hepatocellular carcinoma by EF24, a curcumin analog. Liu H; Liang Y; Wang L; Tian L; Song R; Han T; Pan S; Liu L PLoS One; 2012; 7(10):e48075. PubMed ID: 23118928 [TBL] [Abstract][Full Text] [Related]
2. EF24 induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by increasing PTEN expression. Selvendiran K; Tong L; Vishwanath S; Bratasz A; Trigg NJ; Kutala VK; Hideg K; Kuppusamy P J Biol Chem; 2007 Sep; 282(39):28609-28618. PubMed ID: 17684018 [TBL] [Abstract][Full Text] [Related]
3. Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma. Liang Y; Zheng T; Song R; Wang J; Yin D; Wang L; Liu H; Tian L; Fang X; Meng X; Jiang H; Liu J; Liu L Hepatology; 2013 May; 57(5):1847-57. PubMed ID: 23299930 [TBL] [Abstract][Full Text] [Related]
4. Diphenyl difluoroketone: a curcumin derivative with potent in vivo anticancer activity. Subramaniam D; May R; Sureban SM; Lee KB; George R; Kuppusamy P; Ramanujam RP; Hideg K; Dieckgraefe BK; Houchen CW; Anant S Cancer Res; 2008 Mar; 68(6):1962-9. PubMed ID: 18339878 [TBL] [Abstract][Full Text] [Related]
5. Curcumin analog EF24 induces apoptosis via ROS-dependent mitochondrial dysfunction in human colorectal cancer cells. He G; Feng C; Vinothkumar R; Chen W; Dai X; Chen X; Ye Q; Qiu C; Zhou H; Wang Y; Liang G; Xie Y; Wu W Cancer Chemother Pharmacol; 2016 Dec; 78(6):1151-1161. PubMed ID: 27787644 [TBL] [Abstract][Full Text] [Related]
6. EF24 inhibits tumor growth and metastasis via suppressing NF-kappaB dependent pathways in human cholangiocarcinoma. Yin DL; Liang YJ; Zheng TS; Song RP; Wang JB; Sun BS; Pan SH; Qu LD; Liu JR; Jiang HC; Liu LX Sci Rep; 2016 Aug; 6():32167. PubMed ID: 27571770 [TBL] [Abstract][Full Text] [Related]
7. Diphenyl difluoroketone: a potent chemotherapy candidate for human hepatocellular carcinoma. Liang Y; Yin D; Hou L; Zheng T; Wang J; Meng X; Lu Z; Song X; Pan S; Jiang H; Liu L PLoS One; 2011; 6(8):e23908. PubMed ID: 21901145 [TBL] [Abstract][Full Text] [Related]
8. Activation of the p38 pathway by a novel monoketone curcumin analog, EF24, suggests a potential combination strategy. Thomas SL; Zhao J; Li Z; Lou B; Du Y; Purcell J; Snyder JP; Khuri FR; Liotta D; Fu H Biochem Pharmacol; 2010 Nov; 80(9):1309-16. PubMed ID: 20615389 [TBL] [Abstract][Full Text] [Related]
9. The curcumin analog EF24 targets NF-κB and miRNA-21, and has potent anticancer activity in vitro and in vivo. Yang CH; Yue J; Sims M; Pfeffer LM PLoS One; 2013; 8(8):e71130. PubMed ID: 23940701 [TBL] [Abstract][Full Text] [Related]
10. EF24 Suppresses Invasion and Migration of Hepatocellular Carcinoma Cells Zhao R; Tin L; Zhang Y; Wu Y; Jin Y; Jin X; Zhang F; Li X Biomed Res Int; 2016; 2016():8569684. PubMed ID: 27999817 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis. Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993 [TBL] [Abstract][Full Text] [Related]
12. A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapies. Bisht S; Schlesinger M; Rupp A; Schubert R; Nolting J; Wenzel J; Holdenrieder S; Brossart P; Bendas G; Feldmann G J Nanobiotechnology; 2016 Jul; 14(1):57. PubMed ID: 27401816 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of IkappaB kinase-nuclear factor-kappaB signaling pathway by 3,5-bis(2-flurobenzylidene)piperidin-4-one (EF24), a novel monoketone analog of curcumin. Kasinski AL; Du Y; Thomas SL; Zhao J; Sun SY; Khuri FR; Wang CY; Shoji M; Sun A; Snyder JP; Liotta D; Fu H Mol Pharmacol; 2008 Sep; 74(3):654-61. PubMed ID: 18577686 [TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic effects of pazopanib in xenograft hepatocellular carcinoma models: evaluation by quantitative contrast-enhanced ultrasonography. Zhu XD; Zhang JB; Fan PL; Xiong YQ; Zhuang PY; Zhang W; Xu HX; Gao DM; Kong LQ; Wang L; Wu WZ; Tang ZY; Ding H; Sun HC BMC Cancer; 2011 Jan; 11():28. PubMed ID: 21251271 [TBL] [Abstract][Full Text] [Related]
15. Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584. Liu Y; Poon RT; Li Q; Kok TW; Lau C; Fan ST Cancer Res; 2005 May; 65(9):3691-9. PubMed ID: 15867364 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of the NF-κB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties. Olivera A; Moore TW; Hu F; Brown AP; Sun A; Liotta DC; Snyder JP; Yoon Y; Shim H; Marcus AI; Miller AH; Pace TW Int Immunopharmacol; 2012 Feb; 12(2):368-77. PubMed ID: 22197802 [TBL] [Abstract][Full Text] [Related]
17. The Curcumin Analog EF24 Inhibits Proliferation and Invasion of Triple-Negative Breast Cancer Cells by Targeting the Long Noncoding RNA HCG11/Sp1 Axis. Duan Y; Chen HL; Ling M; Zhang S; Ma FX; Zhang HC; Lv XA Mol Cell Biol; 2022 Jan; 42(1):e0016321. PubMed ID: 34780286 [TBL] [Abstract][Full Text] [Related]
18. EF24 induces ROS-mediated apoptosis via targeting thioredoxin reductase 1 in gastric cancer cells. Zou P; Xia Y; Chen W; Chen X; Ying S; Feng Z; Chen T; Ye Q; Wang Z; Qiu C; Yang S; Liang G Oncotarget; 2016 Apr; 7(14):18050-64. PubMed ID: 26919110 [TBL] [Abstract][Full Text] [Related]
19. Multiple anticancer activities of EF24, a novel curcumin analog, on human ovarian carcinoma cells. Tan X; Sidell N; Mancini A; Huang RP; Shenming Wang ; Horowitz IR; Liotta DC; Taylor RN; Wieser F Reprod Sci; 2010 Oct; 17(10):931-40. PubMed ID: 20693500 [TBL] [Abstract][Full Text] [Related]
20. Vitexin suppresses autophagy to induce apoptosis in hepatocellular carcinoma via activation of the JNK signaling pathway. He JD; Wang Z; Li SP; Xu YJ; Yu Y; Ding YJ; Yu WL; Zhang RX; Zhang HM; Du HY Oncotarget; 2016 Dec; 7(51):84520-84532. PubMed ID: 27588401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]